Latest Financial News
Roivant climbs 4% on brepocitinib data despite Q3 earnings miss
Phase 2 cutaneous sarcoidosis results show 21.6-point improvement versus placebo as NDA filed for dermatomyositis
Canopy Growth narrows loss 49% as Canada medical cannabis surges
Cannabis company targets positive adjusted EBITDA in fiscal 2027 despite missing quarterly earnings estimates
uniQure falls 8% on Fabry gene therapy safety concerns, efficacy data
AMT-191 trial shows strong enzyme activity but dose cohorts paused after liver toxicity, stroke
Virtus shares slide as $8.1bn quarterly outflows accelerate
Asset manager reports revenue beat but widening client departures pressure AUM and margins
Philip Morris rises on smoke-free growth, upbeat 2026 outlook
ZYN nicotine pouch shipments surge 37% as smoke-free products reach 41.5% of revenue mix
Biogen tops earnings estimates on LEQEMBI growth, cost cuts
Biotech company's 2026 profit forecast exceeds analyst expectations amid Alzheimer's drug momentum
nVent shares slip despite strong Q4 earnings and bullish 2026 guidance
Electrical solutions provider posts 42% revenue growth and raises dividend, but margin concerns weigh on investor sentiment
Graham shares climb after Q3 beat, guidance raise
Record backlog, strong defense exposure support revised FY26 outlook